BIOMERICA, INC.

NASDAQ:BMRA
Annual Meeting

of Shareholders

MEETING DATE

12/11/2026
DEF 14A FILED
10/16/2026
PUBLISHED
10/16/2026 9:00 pm
TIME TO PUBLISH
10/18/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:BMRA · CUSIP 09061H307 · CLASS common stock, $0.08 par value per share · CIK 0000073290

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

5
FOR
0
AGAINST
0
WITHHOLD
5
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To elect five directors, each to serve until the next annual meeting of stockholders and until his or her successor has been elected and qualified or until his or her earlier resignation, death or removal.
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated five directors and recommends a FOR vote for each nominee.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To approve, on a non-binding advisory basis, the compensation paid to our named executive officers as disclosed in this proxy statement.
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board states it will consider significant negative voting results in future executive compensation decisions.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To ratify the selection of Haskell & White LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2027.
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Audit Committee discussed independence with Haskell & White LLP and approved all services in advance.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
To approve an amendment to our 2024 Stock Incentive Plan to increase the number of shares of common stock, $0.08 par value per share, authorized for issuance under the 2024 Incentive Plan by 150,000 shares.
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The amendment would increase authorized shares under the 2024 Stock Incentive Plan by 150,000 shares.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
To approve an adjournment of the Annual Meeting.
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The proposal permits adjournment if necessary or appropriate, including to establish a quorum.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

1157f802d91ce9c4bdd8f8952361b606f9590f69d1d179b7e2cec689ea6f7958

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates